MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
-$22,586,526
Free Cash flow
-$6,421,902
Unit: Dollar
Positive Cash Flow Breakdown
    • Accounts payable and accrued exp...
    • Stock-based compensation expense
    • Accounts receivable
    • Others
Negative Cash Flow Breakdown
    • Net (loss) income
    • Cash paid in business combinatio...
    • Repayments on notes payable
    • Others

Cash Flow
2026-06-30
Net (loss) income
-17,791,065
Depreciation expense
64,600
Amortization expense
1,165,154
Amortization of debt discount
0
Amortization of right-of-use asset
106,716
Stock-based compensation expense
3,914,096
Fair value adjustment to contingent consideration
1,412,000
Gain on extinguishment of debt
815,250
Deferred tax benefit
0
Accounts receivable
-3,253,111
Inventory
1,834,615
Prepaid expenses and other assets
364,256
Accounts payable and accrued expenses
4,911,963
License fees payable
-295,200
Income tax payable
-31,512
Accrued interest
99,083
Other current and long-term liabilities
-158,802
Net cash (used in) provided by operating activities
-6,363,977
Purchases of property and equipment and construction-in- process
57,925
Cash paid in business combination
15,018,371
Net cash used in investing activities
-15,076,296
Repayments on notes payable
3,500,000
Proceeds from issuance of common stock
2,500,000
Cash paid to third parties for issuance of common stock
146,253
Issuance of common stock for warrant exercise
0
Net cash used in financing activities
-1,146,253
Cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), excluding exchange rate effect, including discontinued operation, total
-22,586,526
Balance, beginning of period
29,549,018
Balance, end of period
6,962,492
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Cash, cashequivalent, restricted...-$22,586,526 Accounts payable andaccrued expenses$4,911,963 Stock-based compensationexpense$3,914,096 Accounts receivable-$3,253,111 Fair valueadjustment to contingent...$1,412,000 Amortization expense$1,165,154 Amortization of right-of-useasset$106,716 Accrued interest$99,083 Depreciation expense$64,600 Proceeds from issuance ofcommon stock$2,500,000 Net cash used ininvesting activities-$15,076,296 Net cash (used in)provided by operating...-$6,363,977 Net cash used infinancing activities-$1,146,253 Canceled cashflow$14,926,723 Canceled cashflow$2,500,000 Cash paid in businesscombination$15,018,371 Purchases of property andequipment and...$57,925 Net (loss) income-$17,791,065 Repayments on notes payable$3,500,000 Inventory$1,834,615 Gain onextinguishment of debt$815,250 Prepaid expenses andother assets$364,256 License fees payable-$295,200 Other current andlong-term liabilities-$158,802 Income tax payable-$31,512 Cash paid to thirdparties for issuance of...$146,253

BioStem Technologies, Inc. (BSEM)

BioStem Technologies, Inc. (BSEM)